Will Bausch (BHC) Gain on Rising Earnings Estimates?

Core Viewpoint - Bausch Health (BHC) is positioned as a strong investment opportunity due to its improving earnings outlook and analysts' increasing earnings estimates [1][2]. Earnings Estimate Revisions - Analysts are showing growing optimism regarding Bausch's earnings prospects, which is expected to positively influence the stock price [2]. - The current-quarter earnings estimate is projected at $1.23 per share, reflecting a year-over-year increase of +7.0% [6]. - The Zacks Consensus Estimate for the current quarter has risen by 8.55% over the last 30 days, with two estimates increasing and no negative revisions [6]. - For the full year, the earnings estimate stands at $3.85 per share, indicating a year-over-year decline of -2.8% [7]. - The consensus estimate for the current year has increased by 7.55% due to three upward revisions and no negative changes [7][8]. Zacks Rank and Performance - Bausch Health has achieved a Zacks Rank 2 (Buy), indicating favorable conditions for investment based on the positive estimate revisions [9]. - Historically, stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have significantly outperformed the S&P 500 [9]. - Bausch shares have appreciated by 9.9% over the past four weeks, suggesting investor confidence in the company's earnings growth potential [10].